These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Masoudi FA; Gross CP; Wang Y; Rathore SS; Havranek EP; Foody JM; Krumholz HM Circulation; 2005 Jul; 112(1):39-47. PubMed ID: 15983243 [TBL] [Abstract][Full Text] [Related]
28. Usefulness of spironolactone in a specialized heart failure clinic. Sligl W; McAlister FA; Ezekowitz J; Armstrong PW Am J Cardiol; 2004 Aug; 94(4):443-7. PubMed ID: 15325926 [TBL] [Abstract][Full Text] [Related]
29. [Therapy of heart insufficiency using aldosterone antagonists]. Krauss J Z Allgemeinmed; 1973 Jul; 49(21):989-91. PubMed ID: 4756071 [No Abstract] [Full Text] [Related]
30. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia. Cruz CS; Cruz LS; Domingues GS; Souza CA Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447 [TBL] [Abstract][Full Text] [Related]
31. Aldosterone antagonism and atrial fibrillation: time for clinical assessment? Nattel S Eur Heart J; 2005 Oct; 26(20):2079-80. PubMed ID: 16141259 [No Abstract] [Full Text] [Related]
32. Update on the treatment of heart failure. Havranek EP; Weinberger J Prog Cardiovasc Nurs; 1999; 14(3):111-3. PubMed ID: 10549049 [No Abstract] [Full Text] [Related]
33. Fracture risk in men with congestive heart failure risk reduction with spironolactone. Carbone LD; Cross JD; Raza SH; Bush AJ; Sepanski RJ; Dhawan S; Khan BQ; Gupta M; Ahmad K; Khouzam RN; Dishmon DA; Nesheiwat JP; Hajjar MA; Chishti WA; Nasser W; Khan M; Womack CR; Cho T; Haskin AR; Weber KT J Am Coll Cardiol; 2008 Jul; 52(2):135-8. PubMed ID: 18598893 [TBL] [Abstract][Full Text] [Related]
34. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. Ko DT; Juurlink DN; Mamdani MM; You JJ; Wang JT; Donovan LR; Tu JV J Card Fail; 2006 Apr; 12(3):205-10. PubMed ID: 16624686 [TBL] [Abstract][Full Text] [Related]
35. Considerations of aldosterone in congestive heart failure, arrhythmias and sudden cardiac death. Editorial overview. Castaigne A Am J Cardiol; 1990 Jun; 65(23):39K-40K. PubMed ID: 2353667 [No Abstract] [Full Text] [Related]
36. Spironolactone in the management of congestive heart failure. Muller JE Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671 [TBL] [Abstract][Full Text] [Related]